281 related articles for article (PubMed ID: 30415162)
1. HDV evolution-will viral resistance be an issue in HDV infection?
Tabernero D; Cortese MF; Buti M; Rodriguez-Frias F
Curr Opin Virol; 2018 Oct; 32():100-107. PubMed ID: 30415162
[TBL] [Abstract][Full Text] [Related]
2. Treatment of delta hepatitis.
Gunsar F
Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
Castelnau C; Le Gal F; Ripault MP; Gordien E; Martinot-Peignoux M; Boyer N; Pham BN; Maylin S; Bedossa P; Dény P; Marcellin P; Gault E
Hepatology; 2006 Sep; 44(3):728-35. PubMed ID: 16941695
[TBL] [Abstract][Full Text] [Related]
4. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
5. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
Zhang Z; Urban S
J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
[TBL] [Abstract][Full Text] [Related]
6. A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
Buchmann B; Döhner K; Schirdewahn T; Sodeik B; Manns MP; Wedemeyer H; Ciesek S; von Hahn T
Antiviral Res; 2017 May; 141():116-123. PubMed ID: 28223128
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis delta and HIV infection.
Calle Serrano B; Manns MP; Wedemeyer H
Semin Liver Dis; 2012 May; 32(2):120-9. PubMed ID: 22760651
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection.
Aziz S; Rajper J; Noor-ul-Ain W; Mehnaz A; Masroor M; Chang MH
J Coll Physicians Surg Pak; 2011 Dec; 21(12):735-40. PubMed ID: 22166693
[TBL] [Abstract][Full Text] [Related]
9. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.
Homs M; Rodriguez-Frias F; Gregori J; Ruiz A; Reimundo P; Casillas R; Tabernero D; Godoy C; Barakat S; Quer J; Riveiro-Barciela M; Roggendorf M; Esteban R; Buti M
PLoS One; 2016; 11(6):e0158557. PubMed ID: 27362848
[TBL] [Abstract][Full Text] [Related]
11. Emerging concepts for the treatment of hepatitis delta.
Elazar M; Glenn JS
Curr Opin Virol; 2017 Jun; 24():55-59. PubMed ID: 28475945
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H;
Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356
[TBL] [Abstract][Full Text] [Related]
13. Combination of Novel Therapies for HDV.
Elazar M; Glenn JS
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215860
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
[TBL] [Abstract][Full Text] [Related]
15. Targeting Hepatitis D.
Rizzetto M
Semin Liver Dis; 2018 Feb; 38(1):66-72. PubMed ID: 29471567
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection.
Godoy C; Tabernero D; Sopena S; Gregori J; Cortese MF; González C; Casillas R; Yll M; Rando A; López-Martínez R; Quer J; González-Aseguinolaza G; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2019 Apr; 25(13):1566-1579. PubMed ID: 30983817
[TBL] [Abstract][Full Text] [Related]
17. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
Heidrich B; Yurdaydın C; Kabaçam G; Ratsch BA; Zachou K; Bremer B; Dalekos GN; Erhardt A; Tabak F; Yalcin K; Gürel S; Zeuzem S; Cornberg M; Bock CT; Manns MP; Wedemeyer H;
Hepatology; 2014 Jul; 60(1):87-97. PubMed ID: 24585488
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.
Borzacov LM; de Figueiredo Nicolete LD; Souza LF; Dos Santos AO; Vieira DS; Salcedo JM
Int J Infect Dis; 2016 May; 46():82-8. PubMed ID: 27005283
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression.
Shirvani-Dastgerdi E; Amini-Bavil-Olyaee S; Alavian SM; Trautwein C; Tacke F
Clin Microbiol Infect; 2015 May; 21(5):510.e11-23. PubMed ID: 25656625
[TBL] [Abstract][Full Text] [Related]
20. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
Goyal A; Murray JM
Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
